PRGS
Progress Software Corporation has made a resounding statement with its first quarter 2026 financial results, surpassing expectations and solidifying its position as a leader in the industry. The company reported revenue of $248 million, a significant 4% increase from the same period last year. In a call with investors and
JFIN
Jiayin Group, a leading online consumer finance company in China, has reported strong financial results for its fourth quarter and full year 2025, despite the challenges posed by deepening regulation and standardized development in the industry. In a recent conference call, Mr. Yan Dinggui, Chief Executive Officer of Jiayin Group,
PHR
Phreesia, a leading healthcare technology company, recently concluded its fourth quarter and fiscal year 2026 earnings conference call. The event highlighted the company's significant progress in various growth initiatives, culminating in several record-breaking financial milestones. During the call, Chaim Indig, Phreesia's CEO, emphasized that the fiscal
BLNK
The Blink Charging Co. has marked a significant transformation in its history, according to CEO Mike Battaglia during the company's fourth quarter and full-year 2025 earnings conference call. During the call, Battaglia reported that the company has substantially met its 2025 objectives with its Blink Forward initiative, representing
BRZE
The latest fiscal quarter from Braze has brought about outstanding results that further solidify the company's position as a leader in customer engagement. In a recent conference call, Braze officials reported $205 million of revenue, representing an 8% increase from the prior quarter and a 28% year-over-year growth.
ENLV
March 25, 2026 - Enlivex has reported a defining year for the company, marked by significant milestones in its dual-engine model that combines clinical stage platform advancements with a treasury architecture designed to capture value from emerging prediction markets. Speaking during the Q4 2025 conference call, Executive Chairman Shai Novik
VELO
Velo3D, the pioneering additive manufacturing company, has concluded a remarkable year in 2025. In its fourth quarter earnings call, CEO Arun Jeldi proudly announced double-digit revenue growth, driven by accelerating demand for their Rapid Production Solutions and large format additive manufacturing capabilities. The company's record bookings and substantial
TELA
Tela Bio, a leading player in the medical device industry, has reported a stellar fourth quarter and full year 2025 earnings performance. The company's strong commercial foundation, bolstered by strategic changes, has enabled it to achieve record revenues and drive durable growth. TELABio's CEO, Tony Koblish,
NRXP
The latest conference call transcript from NRx Pharmaceuticals has revealed a transformative year for the company, with significant advancements in its development programs and a renewed outlook on profitability. Dr. Jonathan Javitt, Founder, Chairman, and CEO of NRx, expressed optimism during the call, stating that 2025 was a "pivotal
ACHV
Achieve Life Sciences is making headlines in the medical community with its latest achievements. The company has recently submitted a new drug application (NDA) for cytisinicline, a novel treatment for nicotine dependence, which marks a significant milestone in the development of this life-changing medication. According to Rick Stewart, President and
RICK
Despite continued economic uncertainty, RCI Hospitality Holdings (RCI) demonstrated resilience in its fourth quarter results. The company's nightclub revenues remained nearly level, a testament to its ability to adapt to changing market conditions. In the latest conference call transcript reported on March 19, 2026, Travis Reese, Interim President
RLMD
In a recent conference call, Relmada Therapeutics provided an update on its fourth quarter and full year 2025 financial results. The company reported significant progress in its lead program, NDV-01, which is being developed for the treatment of Non-Muscle Invasive Bladder Cancer (NMIBC). According to Dr. Sergio Traversa, Relmada'